مقالات
مقالات در ژورنالهاي علمي بين المللي
Author of Publications In International Journal
1. Zamani M, Decorte R, Buyse I, Gu XX, Spaepen M, Marynen P, De Canck l, Emonds M and Cassiman JJ (1994): Distribution of HLA Class II genes in a Caucasian population as determined by PCR and reversed-dot-blot typing. Forensic Haemogenet. 5:490-492.
2. Zamani M, Vandevyver C, Buyse I, Philippaerts L, Medaer R, Carton H, Cassiman JJ and Raus J (1994): HLA and T-cell receptor polymorphisms in Belgian multiple sclerosis patients. J of Neuroimmonology 52:25-32.
3. Zamani M, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H and Cassiman JJ (1995): Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRB1 chain in Multiple Sclerosis. J of Neuroimmonology 59:77-82.
4. Zamani M, Huang C, Spaepen M, Buyse I, Gu XX, Bouillon R, and Cassiman JJ (1997):Belgium: Insulin-dependent diabetes mellitus. pp 373, Non insulin-dependent diabetes mellitus. pp 394, Belgium: Multiple Sclerosis. PP 391, Belgium: Schizophrenia. pp 415; BooK; HLA 1997, Published by UCLA Tissue Typing Laboratory USA.
5. Zamani M, Kiristiansen OP, Johannesen J, Mandrup-Poulsen T, Cassiman JJ, Nerup J, Pociot F, DIEGG and DSGD(1998): Linkage between a CD4 gene polymorphism and IDDM in Danish IDDM patients. Diabetes 47:281-283.
6. Zamani M, Pandey J, Cassiman JJ. (1999) : Epistatic effects of genes encoding tumor necrosis factor a, immunoglobulin allotypes, and HLA antigens on susceptibility to non-insulin dependent (type 2) diabetes. Immunogenetics 49:860-864.
7. Zamani M, Huang C, Spaepen M and Cassiman JJ and (2001): Linkage and association of the HLA class II genes with vitiligo in Dutch families. British j of Dermatology 144:90-94
8. Zamani M and Alibahksh R. (2006): Mutation analysis of CFTR gene in 70 Iranian pationts by ARMS-PCR. Iranian J Allergy, Asthma and Immunology 5:3-8
9. Zamani M, Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH. (2012): The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian multiple sclerosis patients . International Journal of Immunogenetics, 2012, 39, 414–422.
10. Zamani M, Rahmani S.A., Mohadess S.M., Aghazadeh A, Jahani M, Izadyar M, and Mehdipour P. (2006): Investigation of TEL/AML1 and BCR/ABL fusion genes in patients affected by acute lymphoblastic leukaemia using interphase in situ hybridization. Journal of Sciences, .I.R. of Iran 17:17-25
11. Zamani M, Spaepen M, Buyse I, Marynen P, Bex M, Bouillon R and Cassiman JJ (1994): Improved risk assessment for IDDM by analysis of amino acids in HLA- DQ and DRB1 loci. Eur J Human Genetics 2:177-184.
12. Zamani M, Buyse I, Sandkuyl LA, Gu XX, Bouillon R, BeX M, Dooms L, Emonds MP, Duhamel M, Marynen P and Cassiman JJ (1994): Association of particular HLA class II alleles, haplotypes, and genotypes with susceptibility to insulin dependent diabetes mellitus in the Belgian population. Diabetologia 37:808-817.
13. M. Zamani Ghabanbasani, I Buyse, E Legius, R Decorte, P Marynen, R Bouillon, J J Cassiman: Possible association of CD3 and CD4 polymorphisms with insulin-dependent diabetes mellitus (IDDM). Clinical & Experimental Immunology 10/1994; 97(3):517-21.
14. Zamani M, De Hert M, Spaepen M, Hermans M, Marynen P, Cassiman JJ and Peuskens J (1994): Study of the possible association of HLA class II, CD4 and CD3 polymorphisms with schizophrenia. Am J Medical Genetics. 54:372-377.
15. Zamani M, Spaepen M, Buyse I, Legius E, Decorte R, Bex M, Marynen P, Bouillon R and Cassiman JJ (1995): Increased and decreased relative risk for Non- insulin-dependent diabetes mellitus conferred by HLA class II and by CD4 alleles. Clinical Genetics 47:225-230.
16. M.Zamani Ghabanbasani, X X Gu, M Spaepen, C Vandevyver, J Raus, P Marynen, H Carton, J J Cassiman: Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRB1 chain in multiple sclerosis. Journal of Neuroimmunology 07/1995; 59(1-2):77-82.
17. Zamani M, Pociot F, Spaepen M, Raeymaekers P, Nerup J and Cassiman JJ (1996): Linkage and association of the HLA gene complex with IDDM in Danish families: Strong linkage between DRβ1Lys71+ and IDDM. J Medical Genetics 33:899-905.
18. ZMahdi Zamani, Flemming Pociot, Peter Raeymaekers, Jørn Nerup, J J Cassiman: Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Human Genetics 11/1996; 98(4):491-6.
19. O P Kristiansen, M Zamani, J Johannesen, T Mandrup-Poulsen, J J Cassiman, J Nerup, F Pociot: Linkage and association between a CD4 gene polymorphism and IDDM in Danish IDDM patients. The Danish IDDM Epidemiology and Genetics Group, and The Danish Study Group of Diabetes in Childhood. Diabetes 02/1998; 47(2):281-3.
20. Zamani M and Cassiman JJ. (1998) : Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of Different
Populations to type I Diabetes in different populations. Am J Medical Genetics 76:183-194.
21. J. P. Pandey, Mahdi Zamani, Jean-Jacques Cassiman: Epistatic effects of genes encoding tumor necrosis factor-α, immunoglobulin allotypes, and HLA antigens on susceptibility to non-insulin-dependent (type 2) diabetes mellitus. Immunogenetics 08/1999; 49(10):860-864.
22. Zamani M, Spaepen M, Bex M, , Bouillon R and Cassiman JJ (2000): Primary role of the HLA class II DRB1*0301 allele in Graves’ Disease. Am J Medical Genetics: 95:432-437.
23. M Zamani, M Spaepen, S.S. Sghar, C Huang, W Westerhof, L Nieuweboer-Krobotova, J.J. Cassiman: Linkage and association of HLA class II genes with vitiligo in a Dutch population. British Journal of Dermatology 08/2001; 145(1):90-4.
24. Zamani M, Behjati F, Atri m, Najmabadi H, Nouri K and Mehdipour P (2006): Prognostic value of chromosome 1 and 8 copy number in invasive Ductal breast carcinoma among Iranian women: An interphase FISH analysis. Pathology Oncology Research 11:157-163.
25. M. Zamani, M.A. Tabatabaiefar, A.S. Esfahani, F. Mostafavi, A. Sotoudeh, B. Larijani: Correlation between the CD4 gene polymorphism with type 1 diabetes mellitus in the Iranian population. Iranian Journal of Diabetes and Lipid Disorders 06/2005; 4(4):E1+E1i-E1ix.
26. Reza Alibakhshi, Mahdi Zamani: Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iranian journal of allergy, asthma, and immunology 04/2006; 5(1):3-8.
27. M. Zamani Ghabanbasani, X.X. Gu, M. Spaepen, Caroline VANDEVYVER, Jef RAUS, P. Marynen, H. Carton, J.J. Cassiman: Importance of HLA-DRBI and DQA1 genes and the amino acid polymorphisms in the functional domain of DRBI chain in multiple slerosis.
28. Zamani M, Korzebor, K. Nouri and M. H. Modarressi (2007): Statistical analysis of six STR loci located in MHC region in Iranian population for preimplantation genetic diagnosis. International Journal of Immunogenetics 34, 441–443.
29. Mahdi Zamani, Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques Cassiman, and Harry Cuppens (2008): Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations Journal of Cystic Fibrosis7, 102-109.
30. Zamani M, Rahmani SA, Mehdipour P, Aboualsoltani F, Izadyar M, Aghazadeh AM(2009): Investigation of TEL/AML1 and BCR/ABL genes fusion in Acute lymphoblastic leukemia (ALL) Patients and Follow-up Study in 25 Bone Marrow Transplanted (BMT) Patients Using Interphase Fluorescence In Situ Hybridization (FISH) Shiraz E Medical Journal, Vol. 10, No. 4.
31. Mahdi Zamani, Majid Shahbazi , Hamid Ebadi, Davood Fathi, Danial Roshandel, Mana Mahamadhoseeni, Azam Rashidbaghan, Narges Mahammadi and Mahammad Reza Mahammadi. (2009): CCR5-Delta32 Allele is Associated with the Risk of Developing Multiple Sclerosis in the Iranian Population. Cell Mol Neurobiol 29:1205–1209.
32. Zamani M, A. Tabatabaiefar, S. Mosayyebi, A. Mashaghi and P. Mansouri (2010): Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clin Exp Dermatol. 2010 Jul;35(5):521-4.
33. Zamani M, Shahbazi M, Roshandel D, Ebadi H, Fathi D, Boghaee M, Mohammadhoseeeni M, Rshaidbaghan A, Bakhshandeh A, Shahbazi S.(2010): High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clin Immunol. 137:134-8.
34. Zamani M, Shahbazi M, Ebadi H, Fathi D, Roshandel D, Mohamadhosseni M, Tahmasebi A, Shahbazi S, Rashidbaghan A.(2010): HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Mult Scler. 16:1173-7.
35. Mahdi Zamani, Abolfazl Movafagh, Abbas Hajifathali (2011) Secondary Chromosomal Abnormalities of de novo Acute Myeloid Leukemia – A First Report from the Middle East Asian Pacific Journal of Cancer Prevention, Vol 12, 2011.
36. Zamani M, A. Malayeri, M. Panjehpour, A. Movahedian, M. Ghaffarpour, G. R. Hajifaraj Tabrizi and M. Zamani (2010): Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis. Acta Medica Iranica 2011; 49(3): 142-148.
37. Zamani M, M. Mehri, A. Kollaee, P. Yenki, M. Ghaffarpor, M.H. Harirchian, M. Shahbazi (2011): Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients. Dement Geriatr Cogn Disord Extra 1:180–189.
38. Zamani M, V. Salahshour, A.Kollaee, G. R. Zamani, M. Sheidai, M. Mohammadi, and M. Ghaffarpor (2011): Intragenic DNA Polymorphism Analysis of DMD/BMD Dystrophy Gene for Carrier and Prenatal Diagnosis in 60 Iranian Healthy Individuals. International Journal of Neuroscience. 121: 551–556.
39. Zamani M, Kollaee, M. Ghaffarpor, H. Pourmahmoudian, M. Shahbazi (2011): Investigation of CD24 and Its Expression in Iranian Relapsing-Remitting Multiple Sclerosis. International Journal of Neuroscience.121(12):684-90.
40. M Zamani, A Sayad, MT Akbari, M Pajouhi, F Mostafavi (2012) The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DR beta 1 and HLA-DQ beta 1 molecules on risk of Iranian type 1 diabetes mellitus patients International Journal of Immunogenetics 04/2012; 39(5):429-436.
41. Mahdi Zamani, Azadeh Sayad, Mehrdad Noruzinia, Mohammad Hossein Harirchian, and Anoshirvan Kazemnejad (2012) Lipoprotein Lipase HindIII Intronic Polymorphism In A Subset Of Iranian Patientes With Late-Onset Alzhimer’s Disease Cell J. 2012 Spring; 14(1): 67–72.
42.Zamani M, Movafagh A , Ghanati K, Amani D, Mahdavi M, Hashemi M, Zare Abdolahi D, Darvish H, Gholami M, HaghNejad L, Mosammami S, Safari Sh, Darehgazani R, Rahimi M, Safavi Naini N, Ghandehari Motlagh M (2013) The structure Biology and Application of Phytohemagglutinin (PHA) in Phytomedicine: With special up-to-date references to lectins Journal of Paramedical Sciences
43. Zamani M, Karami F, Shirvani F, Kia-Lashaki L, Shahbazkhani B(2013):The Role of CD14 and CTLA4 Gene Polymorphisms in Risk of Celiac Disease among Patients of Iranian Ethnicity. Cell Journal 05/2013; 16(2).
44. Mahdi Zamani, Arezou Sayad, Mohammad Taghi Akbari, Mohammad Pajouhi, Feridoon Mostafavi, Anooshirvan Kazemnejad (2013) Investigation The Role of Gender on The HLA DRB1 and -DQB1 Association with Type 1 Diabetes Mellitus in Iranian Patients Cell Journal(Yakhteh), Vol 15, No 2, Summer 2013, Pages: 108-115.
45. Zamani M, Sayad A, Noruzinia M, Harirchian MH, Kazemnejad A(2014): Association Study of Cathepsin D Gene Polymorphism in Iranian Patients with Sporadic Late-Onset Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders 11/2013; 37(5-6):257-264.
46. Zamani M, Ghlichnia HA, Kollaee A, Gaffarpoor M, Movafagh A, Ghlichnia B(2014): The Influence of Combined Genotypes of the HLADRB1*1501 and CD24 Single Nucleotide Polymorphism on Disease Severity of Iranian Multiple Sclerosis Patients. Acta medica Iranica 06/2014; 52(6):418-23.
47. M Zamani, M Modares-Sadegi, F Shirvani, H Zamani, M H Emami(2014): The involvement of the HLA-DQB1 alleles in the risk and the severity of Iranian coeliac disease patients. International Journal of Immunogenetics 06/2014; 41(4).
48. M Zamani, N Mansouri, A Movafagh, A Sayad, S Ghafouri-Fard, H Darvish, D Zare-Abdollahi, B Emamalizadeh, F Shahvaisizadeh, H Ghaedi, M Bastami, M Kayyal, M Hashemi, Mh Heidari, A Nejatizadeh(2014): Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric Study. 12/2014; 4(4):178-87.
49. Zamani M, Zamani GR, Karami F, Mehdizadeh M, Movafagh A, Nilipour Y(2015): Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation Neurol Sci. 2015 Nov;36(11):2011-7. doi: 10.1007/s10072-015-2290-2. Epub 2015 Jun 17.
50. Zamani M, Mohammadi M, Zamani H, Tavasoli A (2016): Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer’s Patients. Mol Neurobiol. 2016 Sep;53(7):4521-8. doi: 10.1007/s12035-015-9387-8. Epub 2015 Aug 21.
51. Zamani M, Kayyal M, Movafagh A, Hashemi M, Sayad A, Emamalizadeh B, PourIran K, Kayyal M, Amirabadi MR, Darvish H (2015): Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population Pak J Med Sci. 2015 Sep-Oct;31(5):1162-6.
52. Zamani M, Torbati S, Karami F, Ghaffarpour M (2015): Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population. Cell Journal 12/2015; 16(4):506-513.
51. Mahdi Zamani, Wolfram Demaerel, Majid Hosseinzadeh, Nayereh Nouri, Maryam Sedghi, Eftychia Dimitriadou, Mansoor Salehi, Hossein Abdali, Mehrdad Memarzadeh, Joris R Vermeesch (2016): Reciprocal 22q11.2 Deletion and Duplication in Siblings with Karyotypically Normal Parents. Cytogenetic and Genome Research 04/2016; 148(1).
53. Zamani M, Shahbazi M, Abadi JSA, Roshandel D, Koochaki M, Amiri H, Kohansal R, Baghbanian SM (2017): Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis Indian J Med Res 145, June 2017, pp 746-752 DOI: 10.4103/ijmr.IJMR_1225_15.
كتابها:
1. Huang C, Spaepen M, Zamani M, Buyse I, Gu XX, Bouillon R, and Cassiman JJ (1997):Belgium:Insulin-dependent diabetes mellitus. pp 373/ Non insulin-dependent diabetes mellitus. pp 394/ Belgium: Multiple Sclerosis. PP 391
BooK; HLA 1997, Published by UCLA Tissue Typing Laboratory USA
2- مهدي زماني، تازه هاي طب مادر و جنين, فصل اول ؛ اصول ژنتيك پزشكي، ناشر معاونت پژوهشي دانشگاه علوم پزشكي تهران، 1378.
3 – مهدي زماني, ژنتيك بيماريها, فصل اول ؛ ژنتيك پزشكي, فصل نهم؛ تشحيص مولكولي بيماريهاي ژنتيكي قبل و بعد از تولد, ناشر معاونت پژوهشي دانشگاه علوم پزشكي تهران1383 ,(ISBN:964-7445-76-8)
4- مهدي زماني, بيماريهاي عضلاني فصل ششم: ژنتيک بيماريهاي عضلاني ناشر معاونت پژوهشي دانشگاه علوم پزشكي تهران,ISBN:964-7445-47-4) 1384)